192 related articles for article (PubMed ID: 1673486)
1. Natural killer cell stimulatory factor (NKSF) augments natural killer cell and antibody-dependent tumoricidal response against colon carcinoma cell lines.
Lieberman MD; Sigal RK; Williams NN; Daly JM
J Surg Res; 1991 Apr; 50(4):410-5. PubMed ID: 1673486
[TBL] [Abstract][Full Text] [Related]
2. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
[TBL] [Abstract][Full Text] [Related]
3. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
Chehimi J; Starr SE; Frank I; Rengaraju M; Jackson SJ; Llanes C; Kobayashi M; Perussia B; Young D; Nickbarg E
J Exp Med; 1992 Mar; 175(3):789-96. PubMed ID: 1346797
[TBL] [Abstract][Full Text] [Related]
4. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
[TBL] [Abstract][Full Text] [Related]
5. Role of the production of natural killer cell stimulatory factor (NKSF/IL-12) in the ability of B cell lines to stimulate T and NK cell proliferation.
Valiante NM; Rengaraju M; Trinchieri G
Cell Immunol; 1992 Nov; 145(1):187-98. PubMed ID: 1358460
[TBL] [Abstract][Full Text] [Related]
6. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.
D'Andrea A; Rengaraju M; Valiante NM; Chehimi J; Kubin M; Aste M; Chan SH; Kobayashi M; Young D; Nickbarg E
J Exp Med; 1992 Nov; 176(5):1387-98. PubMed ID: 1357073
[TBL] [Abstract][Full Text] [Related]
7. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.
Kobayashi M; Fitz L; Ryan M; Hewick RM; Clark SC; Chan S; Loudon R; Sherman F; Perussia B; Trinchieri G
J Exp Med; 1989 Sep; 170(3):827-45. PubMed ID: 2504877
[TBL] [Abstract][Full Text] [Related]
8. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells.
Wolf SF; Temple PA; Kobayashi M; Young D; Dicig M; Lowe L; Dzialo R; Fitz L; Ferenz C; Hewick RM
J Immunol; 1991 May; 146(9):3074-81. PubMed ID: 1673147
[TBL] [Abstract][Full Text] [Related]
9. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
Chan SH; Perussia B; Gupta JW; Kobayashi M; Pospísil M; Young HA; Wolf SF; Young D; Clark SC; Trinchieri G
J Exp Med; 1991 Apr; 173(4):869-79. PubMed ID: 1672545
[TBL] [Abstract][Full Text] [Related]
10. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
11. Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis.
Bellone G; Trinchieri G
J Immunol; 1994 Aug; 153(3):930-7. PubMed ID: 7517976
[TBL] [Abstract][Full Text] [Related]
12. Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A.
Liljefors M; Nilsson B; Hjelm Skog AL; Ragnhammar P; Mellstedt H; Frödin JE
Int J Cancer; 2003 Jul; 105(5):717-23. PubMed ID: 12740924
[TBL] [Abstract][Full Text] [Related]
13. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
[TBL] [Abstract][Full Text] [Related]
14. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
15. Induction mechanism of human blood CD8+ T cell proliferation and cytotoxicity by natural killer cell stimulatory factor (interleukin-12).
Nabioullin R; Sone S; Nii A; Haku T; Ogura T
Jpn J Cancer Res; 1994 Aug; 85(8):853-61. PubMed ID: 7928632
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12). Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2.
Chan SH; Kobayashi M; Santoli D; Perussia B; Trinchieri G
J Immunol; 1992 Jan; 148(1):92-8. PubMed ID: 1345792
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.
Trinchieri G; Wysocka M; D'Andrea A; Rengaraju M; Aste-Amezaga M; Kubin M; Valiante NM; Chehimi J
Prog Growth Factor Res; 1992; 4(4):355-68. PubMed ID: 1364096
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients.
Sirianni MC; Ansotegui IJ; Aiuti F; Wigzell H
Scand J Immunol; 1994 Jul; 40(1):83-6. PubMed ID: 7913248
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.
D'Andrea A; Aste-Amezaga M; Valiante NM; Ma X; Kubin M; Trinchieri G
J Exp Med; 1993 Sep; 178(3):1041-8. PubMed ID: 8102388
[TBL] [Abstract][Full Text] [Related]
20. Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon cancer.
Jain A; Poonia B; So EC; Vyzasatya R; Burch EE; Olsen HS; Mérigeon EY; Block DS; Zhang X; Schulze DH; Hanna NN; Twadell WS; Yfantis HG; Chan SL; Cai L; Strome SE
Eur J Cancer; 2013 Oct; 49(15):3344-52. PubMed ID: 23871153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
